Stroke Impact Scale 3.0
Stroke Impact Scale 16

Developed by: 
Pamela W. Duncan (USA)

Objective:
To detect consequences of stroke, especially mild to moderate stroke on Quality of Life. Patient and Proxy versions are available.

Copyright:
1999, University of Kansas Medical Center, Kansas City, USA. All Rights Reserved.

Reference publications:

SIS-16: Duncan PW, Lai SM, Bode RK, Perera S, DeRosa J. Stroke Impact Scale-16: A brief assessment of physical function. Neurology. 2003 Jan 28;60(2):291-6
SIS and SIS-16:Lai SM, Perera S, Duncan PW, Bode R. Physical and social functioning after stroke: comparison of the Stroke Impact Scale and Short Form-36. Stroke. 2003 Feb;34(2):488-93
SIS:Version 3.0: Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003 Jul;84(7):950-63
SIS Version 2.0: Duncan PW, Wallace D, Lai SM et al. The Stroke Impact Scale Version 2.0. Evaluation of reliability, validity and sensitivity to change. Stroke 1999;30:2131-2140

Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.


2. Access fees:

Royalty fee:
For-profit companies shall pay the University of Kansas Medical Center Research Institute, Inc. a US$ 3,500 one-time per study fee for the use of the questionnaire and its translations.
The invoice will be directly sent to the user by the University of Kansas Medical Center Research Institute, Inc., according to the information mentioned in the user agreement.

Contact information:
Ms. Elaine Spildbusch
UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE, INC.,
TAX ID: 48-1108830
3901 Rainbow Blvd,
Kansas City, Kansas 66160-7702,
USA
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Distribution fee is requested according to the study design and context of use of the questionnaire:

1. In not-funded academic research (1) and individual clinical practice: free of charge
2. In funded academic research (2) : 300 €* per study + 50 €* per language version requested.
3. In commercial studies (3): 600 €* + 250 €*  per language version requested.

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).

Review copy:

Review copies of the original US English versions available for viewing. Please click here to access the Patient version and click here for the Proxy version. 

Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post.  As soon as we receive it, we will process your request.

More information on SIS on PROQOLID

[ BACK ]